VAPOTHERM UK LTDActive

Company number SC370398Private limited companyIncorporated 2009

Key figures

£594,739+32.1%
Net assets 2024
+137.5%
Average annual growth 2020–2024
0200 k400 k600 k202020232024

VAPOTHERM UK LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m202020232024
Filed accounts2020–2024
202020232024
Profit for the year—125,379144,643
Cash at bank and in hand263,6671,059,734768,959
Total assets1,466,4151,881,5091,685,908
Total liabilities1,360,9891,721,0991,357,794
Net assets / total equity105,426450,096594,739
Average number of employees201720

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2024

The principal activity of the company continued to be that of the sale and distribution of medical products.

As described in the company's latest filed accounts.

Summary: VAPOTHERM UK LTD

Company

VAPOTHERM UK LTD is a private limited company registered with Companies House under company number SC370398. It was incorporated on 21 Dec 2009. Its status is active. The registered office is in Loanhead (EH20). Its nature of business (SIC 2007) is agents specialized in the sale of other particular products (46180).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Profit for the year was £144,643. Net assets were £594,739, up 32.1% on the previous year. Cash at bank and in hand was £768,959. Total assets were £1,685,908 and total liabilities £1,357,794. The company had an average of 20 employees. Figures are available for 3 financial years (2020–2024).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 4 Jan 2027.